Bill Detail
H.R. 10628
Congress: 119
Title
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Summary
No summary published on Congress.gov yet — common for recently introduced bills.
Sponsor
Rep. Nicholas Langworthy [R-NY-23]
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Status as of Sep 29, 10:07 AM · synced 2d ago
Introduced
2026-09-28
Data source mode: congress-gov
Bill Engagement
To amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
Sponsor
Rep. Nicholas Langworthy [R-NY-23]R
Status
Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Cosponsors
5D · 3R
Bipartisan
LDA engagement
No active filings
Introduced
2026-09-28